BioWorld

July 7, 2004

Chiron Takes Over Sagres, Gains Wealth' Of Targets

Looking to boost the value of its recent cancer deal with XOMA Ltd., Chiron Corp. is acquiring Sagres Discovery Inc. for undisclosed terms. (BioWorld Today) Read More

FDA Clears NeutroSpec, Gives Palatin First Product Approval

Despite Pressure, FDA Backing Authorized Generic' Marketing

Novo Taking More Proteins In Deal With ZymoGenetics

Other News To Note

Correction

Today's news in brief

BioWorld

IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa

BioWorld Science

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...

Illustration of head with maze that is missing parts

Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke

BioWorld Science

Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...

New mechanism of action identified for QC-6352

BioWorld Science

QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...

VST Bio’s VB-001 is neuroprotector after stroke

BioWorld Science

At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...